Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Growth hormone-receptor antagonist pegvisomant].

Deutsche medizinische Wochenschrift (1946) - 29 Oct 2004

Herrmann B L, Strasburger C J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acromegaly
Share to Adenoma
Share to Human Growth Hormone
Share to Insulin-Like Growth Factor I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pituitary Neoplasms

Share to Pregnancy

Share to Receptors, Somatotropin

Share to Time Factors

Source

Identifiers

PMID: 15497105
DOI: 10.1055/s-2004-835268

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Growth hormone-receptor antagonist pegvisomant].PMID 15497105Read ↗

Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with AcromegalySemantic proximity Read ↗

Discovery and mechanism of action of pegvisomantSemantic proximity Read ↗

Lessons learned from studies with the growth hormone receptor.Semantic proximity Read ↗

Growth hormone excess and the development of growth hormone receptor antagonists.Semantic proximity Read ↗

[Sulfonylurea receptor].Semantic proximity Read ↗

[Results of treatments with IGF-I].Semantic proximity Read ↗

[GH receptor function and its evaluation].Semantic proximity Read ↗

The pharmacological profile and the clinical efficacy of the world's 1st intravenous calcimimetics; etelcalcetide hydrochloride (Parsabiv®).Semantic proximity Read ↗

Endocrine treatments for short stature.Semantic proximity Read ↗

Therapy for 6.5-7.5 Years with Recombinant Insulin-Like Growth Factor I in Children with Growth Hormone Insensitivity Syndrome: A Clinical Research Center StudySemantic proximity Read ↗

Flutamide metformin for post-menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype.Semantic proximity Read ↗

Small molecules to regulate the GH/IGF1 axis by inhibiting the growth hormone receptor synthesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.